Medtronic GI revenue decreased by 16% in Q2

Medtronic's respiratory, gastrointestinal and renal revenue decreased 16 percent in the second quarter of fiscal year 2023, according to earnings results released on Nov. 22. 

Medtronic's GI revenue reached $671 million, while renal care solutions revenue decreased low-double digits, according to the report. 

Medtronic's organic GI revenue also decreased by 11 percent. Medtronic's overall revenue decreased 3 percent to $7.6 billion worldwide. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast